None
Conditions
Interventions
neostigmine group (Group N):After surgery, when the TOF count was 2, the sugammadex group received 0.03 mg/kg of neostigmine and 0.015 mg/kg of atropine intravenously.
sugammadex group (Group S):After surgery, when the TOF count was 2, the sugammadex group received 2 mg/kg of sugammadex sodium intravenously.
Sponsors
Capital Medical University Affiliated Beijing Children's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Aged 2 to 18 years; ASA grade I-III; Undergoing cardiac catheterization under general anesthesia.
Exclusion criteria
Exclusion criteria: Exclusion criteria: allergy to neuromuscular blocking agents or reversal agents; neuromuscular junction disorders; hepatic and renal failure; parental refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of arrhythmia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate;Blood pressure;Post - operative agitation;The recovery status of muscle relaxation; | — |
Countries
China
Contacts
Public ContactLijing Li
Capital Medical University Affiliated Beijing Children's Hospital
Outcome results
None listed